175 related articles for article (PubMed ID: 27444284)
1. In vivo imaging of tumour xenografts with an antibody targeting the potassium channel K
Napp J; Pardo LA; Hartung F; Tietze LF; Stühmer W; Alves F
Eur Biophys J; 2016 Oct; 45(7):721-733. PubMed ID: 27444284
[TBL] [Abstract][Full Text] [Related]
2. Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin.
Hartung F; Pardo LA
Eur Biophys J; 2016 Oct; 45(7):709-719. PubMed ID: 27350552
[TBL] [Abstract][Full Text] [Related]
3. KV10.1 K(+)-channel plasma membrane discrete domain partitioning and its functional correlation in neurons.
Jiménez-Garduño AM; Mitkovski M; Alexopoulos IK; Sánchez A; Stühmer W; Pardo LA; Ortega A
Biochim Biophys Acta; 2014 Mar; 1838(3):921-31. PubMed ID: 24269539
[TBL] [Abstract][Full Text] [Related]
4. Time-domain in vivo near infrared fluorescence imaging for evaluation of matriptase as a potential target for the development of novel, inhibitor-based tumor therapies.
Napp J; Dullin C; Müller F; Uhland K; Petri JB; van de Locht A; Steinmetzer T; Alves F
Int J Cancer; 2010 Oct; 127(8):1958-74. PubMed ID: 20473895
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Eag1 potassium channels in clinical tumours.
Hemmerlein B; Weseloh RM; Mello de Queiroz F; Knötgen H; Sánchez A; Rubio ME; Martin S; Schliephacke T; Jenke M; Heinz-Joachim-Radzun ; Stühmer W; Pardo LA
Mol Cancer; 2006 Oct; 5():41. PubMed ID: 17022810
[TBL] [Abstract][Full Text] [Related]
6. Kv10.1 potassium channel: from the brain to the tumors.
Cázares-Ordoñez V; Pardo LA
Biochem Cell Biol; 2017 Oct; 95(5):531-536. PubMed ID: 28708947
[TBL] [Abstract][Full Text] [Related]
7. Ether à go-go potassium channel expression in soft tissue sarcoma patients.
Mello de Queiroz F; Suarez-Kurtz G; Stühmer W; Pardo LA
Mol Cancer; 2006 Oct; 5():42. PubMed ID: 17022811
[TBL] [Abstract][Full Text] [Related]
8. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
[TBL] [Abstract][Full Text] [Related]
9. Kv10.1 K(+) channel: from physiology to cancer.
Ouadid-Ahidouch H; Ahidouch A; Pardo LA
Pflugers Arch; 2016 May; 468(5):751-62. PubMed ID: 26743871
[TBL] [Abstract][Full Text] [Related]
10. Optical Imaging of Triple-Negative Breast Cancer Cells in Xenograft Athymic Mice Using an ICAM-1-Targeting Small-Molecule Probe.
Zhang Y; Wang M; Liu W; Peng X
Mol Imaging Biol; 2019 Oct; 21(5):835-841. PubMed ID: 30623283
[TBL] [Abstract][Full Text] [Related]
11. Chloroquine inhibits tumor-related Kv10.1 channel and decreases migration of MDA-MB-231 breast cancer cells in vitro.
Valdés-Abadía B; Morán-Zendejas R; Rangel-Flores JM; Rodríguez-Menchaca AA
Eur J Pharmacol; 2019 Jul; 855():262-266. PubMed ID: 31082369
[TBL] [Abstract][Full Text] [Related]
12. Thallium-sensitive fluorescent assay reveals loperamide as a new inhibitor of the potassium channel Kv10.1.
Loza-Huerta A; Milo E; Picones A; Hernández-Cruz A; Luis E
Pharmacol Rep; 2021 Dec; 73(6):1744-1753. PubMed ID: 34213738
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
14. Procyanidin B1, a novel and specific inhibitor of Kv10.1 channel, suppresses the evolution of hepatoma.
Na W; Ma B; Shi S; Chen Y; Zhang H; Zhan Y; An H
Biochem Pharmacol; 2020 Aug; 178():114089. PubMed ID: 32533968
[TBL] [Abstract][Full Text] [Related]
15. Cyclic expression of the voltage-gated potassium channel KV10.1 promotes disassembly of the primary cilium.
Sánchez A; Urrego D; Pardo LA
EMBO Rep; 2016 May; 17(5):708-23. PubMed ID: 27113750
[TBL] [Abstract][Full Text] [Related]
16. Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels.
Broome AM; Ramamurthy G; Lavik K; Liggett A; Kinstlinger I; Basilion J
Bioconjug Chem; 2015 Apr; 26(4):660-8. PubMed ID: 25775241
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the K
Barriga-Montoya C; Huanosta-Gutiérrez A; Reyes-Vaca A; Hernández-Cruz A; Picones A; Gómez-Lagunas F
Pflugers Arch; 2018 Mar; 470(3):491-503. PubMed ID: 29218452
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival.
Martínez R; Stühmer W; Martin S; Schell J; Reichmann A; Rohde V; Pardo L
BMC Cancer; 2015 Nov; 15():839. PubMed ID: 26530050
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity.
Gómez-Varela D; Zwick-Wallasch E; Knötgen H; Sánchez A; Hettmann T; Ossipov D; Weseloh R; Contreras-Jurado C; Rothe M; Stühmer W; Pardo LA
Cancer Res; 2007 Aug; 67(15):7343-9. PubMed ID: 17671204
[TBL] [Abstract][Full Text] [Related]
20. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.
Ma W; Li G; Wang J; Yang W; Zhang Y; Conti PS; Chen K
Amino Acids; 2014 Dec; 46(12):2721-32. PubMed ID: 25182731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]